Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Ovid Therapeutics Inc.

United States 441 9th Avenue Floor 14, 10001-1649, United States

About the sponsor

Ovid Therapeutics focuses on developing treatments for epilepsy and related seizure disorders.

  • Adjunctive antiseizure agents
  • Pharmacodynamic profiling
  • Drug‑resistant epilepsy

Programs target novel mechanisms of action to improve seizure control.

About Specializations

Ovid Therapeutics Inc. runs clinical trials in conditions such as Epilepsy, Partial seizures, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Epilepsy

Recruiting

Phase 2 Study Evaluating OV329 on Photo‑Induced EEG Response in Adults with Epilepsy

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Ovid Therapeutics Inc.

Partial seizures

Not yet recruiting

Safety and tolerability of OV329 as add‑on therapy in adults with drug‑resistant focal epilepsy

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Ovid Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.